UTILIZING B7-H3 TARGETED THERAPEUTICS TO PREVENT LETHAL PROSTATE CANCER: THE HELP ELUCIDATE & ATTACK LONGITUDINALLY (HEAL) PROSTATE CANCER TRIAL COHORT
$1,473,751FY2025Defense Health AgencyDOD
The Johns Hopkins University
The Johns Hopkins University